STOCK TITAN

[8-K] MOLINA HEALTHCARE, INC. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Molina Healthcare (MOH) filed an 8-K announcing it released its financial results for the third quarter ended September 30, 2025 and updated its full-year 2025 earnings guidance. The company provided these details in a press release attached as Exhibit 99.1.

This is a routine disclosure under Item 2.02, directing readers to the press release for the specific results and guidance figures.

Molina Healthcare (MOH) ha presentato un 8-K annunciando i risultati finanziari del terzo trimestre chiuso il 30 settembre 2025 e ha aggiornato le previsioni di utile per l'intero 2025. L'azienda ha fornito questi dettagli in un comunicato stampa allegato come Esibizione 99.1.

Si tratta di una divulgazione di routine ai sensi della voce 2.02, che invita i lettori al comunicato stampa per i dati specifici sui risultati e sulle previsioni.

Molina Healthcare (MOH) presentó un 8-K anunciando que publicó sus resultados financieros del tercer trimestre finalizados el 30 de septiembre de 2025 y actualizó su guía de ganancias para todo 2025. La empresa proporcionó estos detalles en un comunicado de prensa adjunto como el Anexo 99.1.

Esta es una divulgación de rutina bajo el Item 2.02, que dirige a los lectores al comunicado de prensa para las cifras específicas de resultados y guía.

Molina Healthcare (MOH)는 2025년 9월 30일 종료된 3분기 재무 성과를 발표하고 2025년 전영업연간 이익 가이던스를 업데이트하는 8-K를 제출했습니다. 회사는 이러한 세부 정보를 Exhibit 99.1로 첨부된 보도자료에서 제공했습니다.

이는 Item 2.02에 따른 일상적인 공시로, 특정 결과 및 가이던스 수치를 보도자료로 읽어보도록 독자들에게 안내합니다.

Molina Healthcare (MOH) a déposé un 8-K annonçant la publication de ses résultats financiers du troisième trimestre 2025 clos le 30 septembre 2025 et mis à jour ses prévisions de bénéfice pour l'ensemble de l'année 2025. La société a fourni ces détails dans un communiqué de presse joint en tant qu'Exhibit 99.1.

Il s'agit d'une divulgation de routine en vertu de l'Article 2.02, invitant les lecteurs à consulter le communiqué de presse pour les chiffres spécifiques des résultats et des prévisions.

Molina Healthcare (MOH) hat eine 8-K eingereicht, in der die Finanzergebnisse des dritten Quartals zum 30. September 2025 veröffentlicht und die Jahresprognose für 2025 aktualisiert wurden. Das Unternehmen stellte diese Details in einer als Exhibit 99.1 beigefügten Pressemitteilung bereit.

Dies ist eine routinemäßige Offenlegung gemäß Item 2.02 und weist die Leser auf die Pressemitteilung für die spezifischen Ergebnis- und Prognosezahlen hin.

Molina Healthcare (MOH) قدمت إشعار 8-K يعلن أنها نشرت نتائجها المالية للربع الثالث المنتهي في 30 سبتمبر 2025 وحدثت توجيهات أرباحها للسنة المالية 2025 كاملة. وقد قدّمت الشركة هذه التفاصيل في بيان صحفي مرفق كـ Exhibit 99.1.

هذا disclosure روتيني بموجب البند 2.02، حيث يتم توجيه القرّاء إلى بيان صحفي للحصول على أرقام النتائج والتوجيه المحددة.

Molina Healthcare (MOH) 已提交8-K,宣布其截至2025年9月30日的第三季度财务业绩,并更新了2025年全年盈利指引。公司在附为Exhibit 99.1的新闻稿中提供了这些细节。

这是根据项目2.02的例行披露,指引读者查阅新闻稿以获取具体的业绩与指引数字。

Positive
  • None.
Negative
  • None.

Molina Healthcare (MOH) ha presentato un 8-K annunciando i risultati finanziari del terzo trimestre chiuso il 30 settembre 2025 e ha aggiornato le previsioni di utile per l'intero 2025. L'azienda ha fornito questi dettagli in un comunicato stampa allegato come Esibizione 99.1.

Si tratta di una divulgazione di routine ai sensi della voce 2.02, che invita i lettori al comunicato stampa per i dati specifici sui risultati e sulle previsioni.

Molina Healthcare (MOH) presentó un 8-K anunciando que publicó sus resultados financieros del tercer trimestre finalizados el 30 de septiembre de 2025 y actualizó su guía de ganancias para todo 2025. La empresa proporcionó estos detalles en un comunicado de prensa adjunto como el Anexo 99.1.

Esta es una divulgación de rutina bajo el Item 2.02, que dirige a los lectores al comunicado de prensa para las cifras específicas de resultados y guía.

Molina Healthcare (MOH)는 2025년 9월 30일 종료된 3분기 재무 성과를 발표하고 2025년 전영업연간 이익 가이던스를 업데이트하는 8-K를 제출했습니다. 회사는 이러한 세부 정보를 Exhibit 99.1로 첨부된 보도자료에서 제공했습니다.

이는 Item 2.02에 따른 일상적인 공시로, 특정 결과 및 가이던스 수치를 보도자료로 읽어보도록 독자들에게 안내합니다.

Molina Healthcare (MOH) a déposé un 8-K annonçant la publication de ses résultats financiers du troisième trimestre 2025 clos le 30 septembre 2025 et mis à jour ses prévisions de bénéfice pour l'ensemble de l'année 2025. La société a fourni ces détails dans un communiqué de presse joint en tant qu'Exhibit 99.1.

Il s'agit d'une divulgation de routine en vertu de l'Article 2.02, invitant les lecteurs à consulter le communiqué de presse pour les chiffres spécifiques des résultats et des prévisions.

Molina Healthcare (MOH) hat eine 8-K eingereicht, in der die Finanzergebnisse des dritten Quartals zum 30. September 2025 veröffentlicht und die Jahresprognose für 2025 aktualisiert wurden. Das Unternehmen stellte diese Details in einer als Exhibit 99.1 beigefügten Pressemitteilung bereit.

Dies ist eine routinemäßige Offenlegung gemäß Item 2.02 und weist die Leser auf die Pressemitteilung für die spezifischen Ergebnis- und Prognosezahlen hin.

0001179929false00011799292025-10-222025-10-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2025
______________
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware1-3171913-4204626
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
______________
200 Oceangate, Suite 100,Long Beach,California90802
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (562) 435-3666
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 Par Value MOHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.



Item 2.02.    Results of Operations and Financial Condition.
On October 22, 2025, Molina Healthcare, Inc. (the “Company”) issued a press release reporting its financial results for the third quarter ended September 30, 2025 and updating the Company’s full-year 2025 earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company’s website cited in the press release is not part of this report.
Note: The information in this Form 8-K and the exhibits attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits.
(d)     Exhibits:
Exhibit No.Description
99.1
Press release of Molina Healthcare, Inc., issued October 22, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MOLINA HEALTHCARE, INC.
Date:
October 22, 2025
By:
/s/ Jeff D. Barlow
Jeff D. Barlow
Chief Legal Officer and Secretary


FAQ

What did Molina Healthcare (MOH) announce in this 8-K?

The company reported Q3 2025 financial results and updated its full-year 2025 earnings guidance via an attached press release (Exhibit 99.1).

What period does the update cover for Molina Healthcare (MOH)?

It covers the third quarter ended September 30, 2025, and updates full-year 2025 earnings guidance.

Where can I find the detailed results for MOH?

Detailed results are in the press release included as Exhibit 99.1.

Which 8-K item applies to MOH’s announcement?

Item 2.02, Results of Operations and Financial Condition.

When was the MOH press release issued?

October 22, 2025.

Does the 8-K include website information for MOH?

It notes that any website information cited in the press release is not part of the report.
Molina Hlthcare

NYSE:MOH

MOH Rankings

MOH Latest News

MOH Latest SEC Filings

MOH Stock Data

10.67B
53.50M
1.3%
99.91%
5.4%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
LONG BEACH